By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based Lab21 this week said that it has inked an agreement with "one of the world's leading diagnostic businesses" to develop, manufacture, and distribute a molecular diagnostic product for the detection of Aspergillus to run on the partner's real time PCR platform. Neither the name of the partner nor financial details of the agreement were disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.